Zhu Xianglu1 
,
Gulizhareye Aikula1,
Mukedaisi Baiketiyaer2,
Zhang Yujing2,
Munire Mushajiang1
1Breast Radiology Department of Affiliated Cancer Hospital of Xinjiang Medical University, 830001;
2Radiology Department of Cancer Center of Sun Yat-Sin University, Urumqi City 510000, China.
For correspondence:- Zhu Xianglu
Email: pz1170@163.com
Accepted: 28 December 2018
Published: 31 January 2019
Citation:
Xianglu Z, Aikula G, Baiketiyaer M, Yujing Z, Mushajiang M.
Human leukocyte antigen I and levels of expression of antigen-presenting element proteins plays a role in triple negative breast cancer. Trop J Pharm Res 2019; 18(1):157-165
doi:
10.4314/tjpr.v18i1.24
© 2019 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..
Abstract
Purpose: To determine the protein expression levels of leukocyte antigen I and antigen-presenting element (APM) genes, and to study their relationship with triple negative breast cancer (TNBC) in patients from Uyghur and Han, China.
Methods: Immunohistochemistry was used to determine the expression levels of 10 proteins (HLA-A (Human Leukocyte Antigens-A), HLA-B, HLA-C, TAP1 (Transporter associated with Antigen Processing-1), TAP2, calreticulin, calnexin, ERp57 (Endoplasmic reticulum resident protein 57), ERAP1 (Type 1 tumor necrosis factor receptor shedding aminopeptidase regulator) and tapasin) in TNBC and non-TNBC tissue specimens, and 26 benign lesions (fibrous adenoma) specimens from 120 Uygur and Han women.
Results: Immunohistochemical analysis showed that the positive expressions of HLA-A, HLA-B, TAP2, Erp57, ERAP1, calnexin and calreticulin in breast cancer tissues were significantly lower than those in breast fibroma tissues (p < 0.05). Among the 86 TNBC patients, there were 35 cases of tapasin- (40.70 %), 26 cases of tapasin+ (30.30 %), and 25 cases of tapasin++ (29.10 %). Among the 34 non-TNBC patients, there were 25 cases of tapsin- (73.50 %), 7 cases of tapasin+ (20.60 %) and 2 cases of tapasin ++ (5.9 %). The positive expression of tapasin in TNBC patients was significantly higher than that in non-TNBC patients (p < 0.05).
Conclusion: Down-regulation of transcriptional expression or loss of protein expression of HLA-I and APM genes is closely related to the progression of breast cancer, and is therefore, a potential molecular marker for screening tumors.
Keywords: Triple negative breast cancer, Antigen presenting element, Human leukocyte antigen (HLA)
Fulltext in PDF
